The National Institute for Health and Clinical Excellence (NICE) published a technology appraisal ‘Guidance on the use of long-acting insulin analogues for the treatment of diabetes—insulin glargine’ in December 2002.
However, the choice of insulin prescribed to a patient is a clinical decision made as a result of a joint decision-making process between the patient and their clinician taking into account all available evidence and the individuals specific clinical needs.
From January 2006, the NICE guidance on patient education has required all primary care trusts to implement NICE recommendations by providing all people with diabetes with high quality, structured education which should include information on insulin use.